Sugemalimab
Product Specifications
CAS Number
2256084-03-2
Target
PD-1/PD-L1
Related Pathways
Apoptosis, Immunology/Inflammation, Cell Cycle/Checkpoint
Purity
0.95
Bioactivity
Sugemalimab (CS1001) is a fully humanized, full-length monoclonal antibody targeting PD-L1. It cross-links PD-L1-positive tumor cells with macrophages, inducing antibody-dependent cellular cytotoxicity. Sugemalimab is being studied for EGFR mutation-negative and ALK-negative metastatic non-small cell lung cancer (NSCLC), advanced solid tumors, and lymphoma.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
246137-FITC 100 µL
FKBP10 (FK506 Binding Protein 10, 65kD, FKBP6, FKBP65, FLJ20683, FLJ22041, FLJ23833, hFKBP65) (FITC)
Sign In for Pricing
View Details 
MBS6190973-01 0.1 mL
LIPG (Endothelial Lipase, Endothelial Cell-derived Lipase) (MaxLight 405)
Sign In for Pricing
View Details